Abstract
Despite improved diagnostic monitoring and new therapeutic modalities, sepsis remains a serious cause of mortality in most surgical intensive care units (Parker and Parillo 1983). While the patient’s outcome following severe injury or transplantation has been improved, patients still run the risk of developing sepsis due to immunesuppressive therapy and to the increasing use of intravenous catheters (e.g., for various parenteral applications).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aasen AO, Ruud TE, Pillgram-Larsen J, Stadaas JO (1987) Multi-therapy: a new treatment regimen in endotoxemia. Prog Clin Biol Res 236A:211–225.
Aasen AO, Rishovd AL, Stadaas JO (1989) Role of endotoxin and proteases in multiple organ failure. Prog Clin Biol Res 308:305–314.
Abraham E, Shoemaker WC, Bland RD, Cobo JC (1983) Sequential cardiorespiratory patterns in septic shock. Crit Care Med 11:799–803.
Adnot S, Lefort J, Braquet P, Vargaftig BB (1987) Interference of PAF acether antagonist BN 52021 with Endotoxin induced hypotension in the guinea pig. Prostaglandins 32:791–802.
Alexander HR, Doherty GM, Fraker DL, Block MI, Swedenborg JE, Norton JA (1991) Human recombinant interleukin 1 alpha protection against the lethality of endotoxin and experimental sepsis in mice. J Surg Res 50:421–424.
Arita H, Ogle CK, Alexander JW, Warden GD (1988) Induction of hypermetabolism in guinea pigs by endotoxin infused through the portal vein. Arch Surg 123: 1420–1424.
Backmann W, Harms E, Hassels B, Henninger H, Reutter W (1977) Studies on rat liver plasma membrane. Altered protein and phospholipid metabolism after injection of D-galactosamine. Biochem J 166: 455–462.
Bahrami S, Schiesser A, Redl H, Schlag G (1987) Comparison of different corticosteroids in rat endotoxemia. Prog Clin Biol Res 236-B:273–286.
Bahrami S, Paul E, Redl H, Schlag G (1988) Endotoxemia in rats — influence of lipoxygenase blocker versus leukotriene receptor antagonist (BW755C vs LY171883). In: Levin J, BĂ¼ller HR, Ten Cate JW, van Deventer SJH, Sturk A (eds) Bacterial endotoxins: pathophysiological effects, clinical significance, and pharmacological control. Liss, New York, pp 283–292.
Bahrami S, Paul E, Redl H, Schlag G (1989) Therapeutic modalities to ameliorate endotoxin induced DIC in the rats. Prog Clin Biol Res 308:977–982.
Bahrami S, Redl H, Buurman WA, Schlag G (1991) Endotoxin shock related disorders induced by high-vs low-dose lipopolysaccharide (LPS) injection in rats. Eur Surg Res 23/S1:60.
Baker CC, Niver-Fairchild T, Caragnano C, Kupper TS (1991) Outcome following femur fracture and subsequent cecal ligation and puncture in endotoxin sensitive C3H HeN and endotoxin resistant C3H/HeJ mice. J Surg Res 50:170–174.
Bartoleyns J, Freudenberg MA, Galanos C (1987) Growing tumors induce hypersensitivity to endotoxin and tumor necrosis factor. Infect Immun 55:2230–2233.
Bautista AP, Spitzer JJ (1990) Superoxide anion generation by in situ perfused rat liver: effect of in vivo endotoxin. Am J Physiol 259:G907–G912.
Biber B, Schaefer CF, Smolik MJ, Lener MR, Brackett DJ, Wilsons MF, Fragraeus L (1988) Improved techniques for cardiovascular monitoring in rats as applied during endotoxemia. Am J Physiol 254:H181–H186.
Bone RC (1991) Let’s agree on terminology: definitions of sepsis. Crit Care Med 19:973–976.
Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317: 653–658.
Brackett DJ, Schaefer CF, Tompkins P, Fagraeus L, Peters LJ, Wilson MF (1985) Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia. Circ Shock 12: 273–284.
Breen RE, Connell RS, Harrison MW (1982) The effects of PGE1 and ibuprofen on endotoxin induced pulmonary dysfunction: a biochemical and electron microscopy study. Circ Shock 9:197.
Buchanan BJ, Filkins JP (1976) Hypoglycemic depression of RES function. Am J Physiol 231:265–269.
Bult H, Herman AG, Rampart M (1985) Modification of endotoxin induced haemodynamic and haematological changes in the rabbit by methylprednisolon F(ab’)2 fragments and rosmarinic acid. Br J Pharmacol 84:317–327.
Bureau M, Sourouille P, Brun-Pascaud M, Fey M, Pocidalo J (1985) Hyperoxia effects on lung vascular circulating and marginated leukocytes in the rat. Bull Eur Physiopathol Respir 21:325–329.
Chang SW, Fernyak S, Voelkel NF (1990) Beneficial effect of a platelet activating factor antagonist WEB 2086 on endotoxin induced lung injury. Am J Physiol 258:H153–H158.
Cheadle WG, Ausobsky JR, Trachtenberg LS, Lamont P, Polk HC (1986) Effects of muramyl dipeptide and lead acetate on carbon clearance and endotoxin-induced mortality in mice. Am Surg 52:613–617.
Cohen MM, Greenway CV, Innes IR, Lister GE, Mrthy VS, Scott GD (1973) Further observations of mesenteric vasoconstriction, survival and the clotting defect after endotoxin administration. Br J Pharmacol 48: 555–569.
Cook JA, Hoffmann EO, DiLuzio NR (1975) Influence of lead and cadmium on the susceptibility of rats to bacterial challenge. Proc Soc Exp Biol Med 150: 741–743.
Czaja MJ, Flanders KC, Biempica L, Klein C, Zeren MA, Weiner FR (1989) Expression of tumor necrosis factor alpha and transforming growth factor α1 in acute liver injury. Growth Factors 1:219–226.
Danner RL, Elin RJ, Reilly JM, Hosseini JM, Schlesinger TL, Parrillo JE (1988) Endotoxemia in human septic shock. Crit Care Med 16:397.
Dentener MA, Grebe JW, Maessen JG, Buurman WA (1989) Role of tumour necrosis factor in the enhanced sensitivity of mice to endotoxin after exposure to lead. Immunopharmacol Immunotoxicol 11: 321–334.
Deutschman CS, Konstantinides FN, Tsau M, Simmons RL, Cerra FB (1987) Physiology and metabolism in isolated viral septicemia: further evidence of an host-dependent response. Arch Surg 122:21–25.
Ditter H, Matthias FR, Voss R, Lohmann E (1988) Beneficial effects of prostacyclin in a rabbit endotoxin shock model. Thromb Res 51:403–415.
Dunn DL, Bogard WC, Cerra FB (1985) Enhanced survival during murine gram negative bacterial sepsis by use of a murine monoclonal antibody. Arch Surg 120: 50–56.
Elin RJ, Robinson RA, Levine AS, Wolff SM (1975) Lack of clinical usefulness of the limulus test and the diagnosis of endotoxemia. N Engl J Med 292: 521–524.
Emerson TE, Fournel MA, Leach WJ, Edens TB (1987) Protection against disseminated intravascular coagulation and death by antithrombin III in the Escherichia coli endotoxemic rat. Circ Shock 21:1–14.
Etienne A, Hecquet F, Guilmarad C, Soulard C, Braquet P (1987) Inhibition of rat endotoxin induced lethality by BN52021 and BN52062, compounds with PAF acether antagonistic effect and protease inhibitory activity. Int J Tissue React 9:19–26.
Etienne A, Pannetier MC, Soulaard C, Braquet P (1990) Effects of endothelin in the lethality induced by platelet activating factor or endotoxin in the mouse. Circ Shock 32:77–81.
Ferguson JL, Spitzer JJ, Miller H (1978) Effects of endotoxin on regional blood flow in the unanaesthetized guinea pig. J Surg Res 25:236–243.
Feuerstein G, Hallenbeck JM, Vanatta B, Rabinovici R, Perera PY, Vogel SN (1990) Effect of gram-negative endotoxin on levels of serum corticosterone, TNFα, circulating blood cells, and the survival of rats. Circ Shock 30:265–278.
Filkins JP, Cornell RP (1974) Depression of hepatic gluconeogenesis and the hypoglycemia of endotoxin shock. Am J Physiol 227:778–781.
Fink MP, Heard SO (1990) Laboratory models of sepsis and septic shock. J Surg Res 49:1–11.
Fink MP, Morrissey PE, Stein KL, Clement RE, Fiallo V, Gardiner WM (1988) Systemic and regional hemodynamic effects of cyclo-oxygenase and thromboxane synthetase inhibition in normal and hyperdynamic endotoxemic rabbits. Circ Shock 26:41–57.
Fish RE, Spitzer JA (1984) Continuous infusion of endotoxin from a osmotic pump in the conscious, unrestrained rat: a unique model of chronic endotoxemia. Circ Shock 12:135–149.
Fish RE, Burns AH, Lang CH, Spitzer JA (1985) Myocardial dysfunction in a nonlethal, nonshock model of chronic endotoxemia. Circ Shock 16:241–252.
Fish RE, Lang CH, Spitzer JA (1986) Regional blood flow during continuous low dose endotoxin infusion. Circ Shock 18:267–275.
Freudenberg MA, Galanos C (1988) Induction of tolerance to lipopolysaccharide (LPS) D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect Immun 56:1352–1357.
Freudenberg MA, Galanos C (1991) Tumor necrosis factor alpha mediates lethal activity of killed gram negative and gram positive bacteria in D-galactosamine treated mice. Infect Immun 59:2210–2115.
Fukumoto S, Tanaka K (1983) Protective effects of thromboxane A2 synthetase inhibitors on endotoxin shock. Prostaglandins Leukot Med 11:179–188.
Gadina M, Bertini R, Mengozzi M, Zandalasini M, Mantovani A, Ghezzi P (1991) Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid sensitive and glucocorticoid resistant models of endotoxin shock. J Exp Med 173:1305–1310.
Galanos C, Freudenberg MA, Reutter W (1979) Galactosamine induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci USA 76:5939–5943.
Galanos C, Freudenberg MA, Matsuura M, Coumbos A (1988) Hypersensitivity of endotoxin and mechanism of host-response. In: Levin J, BĂ¼ller HR, Ten Cate JW, van Deventer SJH, Sturk A (eds) Bacterial endotoxins: Pathophysiological effects, clinical significance, and pharmacological control. Liss, New York, pp 295–308.
Goran MI, Little RA, Frayn KN, Jones R, Fozzart G (1988) Effect of chronic endotoxaemia on oxygen consumption at different ambient temperatures in the unanaesthetised rat. Circ Shock 25:103–109.
Greenway CV, Lautt WW, Stark RD (1969) Separation of acute and delayed hemodynamic responses to endotoxin in the cat. Am J Physiol 217:518–521.
Greisman SE, Hornick RB, Wagner HN Jr, Woodward WE, Woodward TE (1969) The role of endotoxin during typhoid fever and tularemia in man. IV. The integrity of the endotoxin tolerance mechanism during infection. J Clin Invest 48:613–617.
Groeneveld AB, Bronsveld W, Thijs LG (1986) Hemodynamic determinants of mortality in human septic shock. Surgery 99:140–153.
Groeneveld PHP, Claassen E, Kuper CF, van Rooijen N (1988) The role of macrophages in LPS induced lethality and tissue injury. Immunology 63:521–528.
Hagberg L, Hull R, Hull S, McGhee JR, Michalek SM, Eden CS (1984) Difference in susceptibility of gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun 46:839–844.
Hagman W, Denzlinger C, Keppler D (1984) Role of peptide leukotrienes and their hepatobiliary elimination in endotoxin action. Circ Shock 14:223–235.
Hamburger SA, McCay PB (1989) Endotoxin induced mortality in rats in reduced by nitrones. Circ Shock 29:329–334.
Hemphill FE, Kaeberle ML, Buck WB (1971) Lead suppression of mouse resistance of salmonella typhimurium. Science 172:1031–1036.
Hoffmann EO, Trejo RA, DiLuzio NR, Lamberty J (1972) Ultrastructural alterations of liver and spleen following acute lead administration in rats. Exp Mol Pathol 17:150–157.
Issekutz AC, Bhimji S (1982) Role of endotoxin in the leukocyte infiltration accompanying Escherichia coli inflammation. Infect Immun 36:558–566.
Johnston TD, Hamptono WH, Fry DE (1989) E. coli endotoxin produces hyperdynamic hemodynamics in the rat. Circ Shock 27:320.
Keppler D, Pausch J, Decker K (1974) Selective uridine triphosphate deficiency induced by D-galactosamine in liver and reversed by pyrimidine nucleotide precursors. J Biol Chem 249:211–216.
Kiener PA, Marek F, Rodgers G, Lin PF, Warr G, Desiderio J (1988) Induction of tumor necrosis factor, IFN gamma and acute lethality in mice by toxic and non-toxic forms of lipis A. J Immunol 141:870–874.
Kuttner RE, Schumer W (1984) Altered carbohydrate metabolism in endotoxin tolerant rats after lead sensitization. Circ Shock 13:233–240.
Law WR, Ferguson JL (1988) Naloxone alters organ perfusion during endotoxin shock in conscious rats. Am J Physiol 255:H1106–H1113.
Lehmann V, Freudenberg MA, Galanos C (1987) Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine treated mice. J Exp Med 165:657–663.
Lindahl M, Ljungman A, Bruhn R, Hede R, Tagesson C (1991) Calcium ionophore activated neutrophils pre-stimulated with endotoxin increase pulmonary arterial pressure and vascular leakage in isolated perfused rat lungs: role of platelet activating factor. Exp Lung Res 17:77–89.
Marshall JC, Christou NV, Horn R, Meakins JL (1988) The microbiology of multiple organ failure: the proximal gastrointestinal tract as an occult reservoir of pathogens. Arch Surg 123:309–315.
Martensson L, Davidsson B, Hultkvist U (1989) Model of pulmonary extravasation as an effect of neutropenia in endotoxin shock in guinea pigs. Eur Surg Res 21:319–326.
Mascioli E, Leader L, Flores E, Trimbo S, Bistrian B, Blackburn G (1988) Enhanced survival to in guinea pigs fed IV fish oil emulsion. Lipids 23:623–626.
Matuschak GM, Pinsky MR, Klein EC, van Thiel DH, Rinaldo JE (1990) Effect of D-galactosamine induced acute liver injury on mortality and pulmonary responses to Escherichia coli lipopolysaccharide. Modulation by arachidonic acid metabolites. Am Rev Respir Dis 141:1296–1306.
McDonough KH, Lang CH, Spitzer JH (1985) Effect of cardiotropic agents on the myocardial dysfunction of hyperdynamic sepsis. Circ Shock 17:1–19.
McKechnie K, Furman BL, Parratt JR (1985) Metabolic and cardiovascular effects of endotoxin infusion in conscious unrestrained rats: effects of methylprednisolone and BW755C. Circ Shock 15:205–215.
Montgomery AB, Stager MA, Carrico CJ, Hudson LD (1985) Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 132:485–489.
Moore JN, Cook JA, Morris DD, Halushka PV, Wise WC (1990) Endotoxin induced procoagulant activity eicosanoid synthesis and tumor necrosis factor production by rat peritoneal macrophages: effect of endotoxin tolerance and glucan. Circ Shock 31: 281–295.
Nakao A, Shimohara M (1985) Changes of circulating blood endotoxin analyzed by quantitative assay after intravenous administration of endotoxin. Jpn J Gastroenterol 82:296–300.
Ohlsson K, Björk P, Bergenfeldt M, Hageman R, Thompson RC (1990) Interleukin 1 receptor antagonist reduces mortality from endotoxin shock. Nature 348:550–552.
Okrent DG, Abraham E, Winston D (1987) Cardiorespiratory patterns in viral septicemia. Am J Med 83: 681–686.
Parker JL, Adams HR (1985) Development of myocardial dysfunction in endotoxin shock. Am J Physiol 248:H818–H826.
Parker MM, Parrillo JE (1983) Septic shock: hemodynamics and pathogenesis. J Am Med Assoc 250: 3324–3327.
Parker MM, Shelhamer JH, Backrach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE (1984) Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100: 483–490.
Parker MM, Shelhamer JH, Natanson C, Ailing SW, Parrillo JE (1987) Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med 15:923–929.
Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ (1982) Clinical predictors of the adult respiratory distress syndrome. Am J Surg 144:124–130.
Pomposelli JJ, Flores EA, Blackburn GL, Zeisel SH, Bistrian BR (1991) Diets enriched with Nω fatty acids ameliorate lactic acidosis by improving endotoxin induced tissue hypoperfusion in guinea pigs. Ann Surg 213:166–176.
Revhaug A, Michie HR, Maoson JM, Watters JM, Dinarello CA, Wolff SM, Wilmore DW (1988) Inhibition of cyclo-oxygenase attenuates the metabolic response to endotoxin in humans. Arch Surg 123: 162–170.
Rietschel ETh, Galanos C, LĂ¼deritz O, Westphal O (1982) The chemistry and biology of lipopolysaccharide and their lipid A component. In: Webb DR (ed) Immunopharmacology and the regulation of leukocyte function. Dekker, New York, pp 229–240.
Rosenbaum JZ, Enkel H (1987) Stimulus specific effects of endotoxin on superoxide production by rabbit polymorphonuclear leukocytes. Yale J Biol Med 60: 391–396.
Rosenbaum JT, Martiala KT, Webster RO, Howes El Jr, Goldstein IM (1983) Antiinflammatory effects of endotoxin. Inhibition of rabbit polymorphonuclear leukocyte responses to complement (C 5) derived peptides in vivo and in vitro. Am J Pathol 113:291–299.
Salari H, Walker MJA (1989) Cardiac dysfunction caused by factors released from endotoxin activated macrophages. Circ Shock 27:263–272.
Schade UF (1990) Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor. Circ Shock 31:171–181.
Schade UF, Burmeister I, Engel R, Reinke M, Wolter DT (1989) Lipoxygenase inhibitors suppress formation of tumor necrosis factor in vitro and in vivo. Lymphokine Res 8:245–250.
Schirmer WJ, Schirmer JM, Fry DE (1989) Recombinant human tumor necrosis factor produces hemodynamic changes characteristics of sepsis and endotoxemia. Arch Surg 124:445–448.
Schlag G, Davies J, Redl H, van Vuuren CJJ, Robertson D (1991) A subchronic model of live bacteria sepsis in baboons. Circ Shock 34:61.
Schlayer HJ, Karck U, Ganter U, Hermann R, Decker K (1987) Enhancement of neutrophil adherence to isolated rat liver sinusoidal endothelial cells by supernatants of lipopolysaccharide activated monocytes. Role of tumor necrosis factor. J Hepatol 5:311–321.
Schlayer HJ, Laaff H, Peters T, Woort-Menker M, Estler HC, Karck U, Schaefer HE, Decker K (1988) Involvement of tumor necrosis factor in endotoxin triggered neutrophil adherence to sinusoidal endothelial cells of mouse liver and its modulation in acute phase. J Hepatol 7:239–249.
Schramek S, Kazar J, Sekeyova Z, Freudenberg MA, Galanos C (1984) Induction of hyperreactivity to endotoxin in mice by Coxiella burnetii. Infect Immun 45: 713–717.
Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ (1990) Structure and function of lipopolysaccharide binding protein. Science 249:1429–1431.
Selye H, Tuchweber B, Bartok L (1966) Effect of lead acetate on the susceptibility of rats to bacterial endotoxins. J Bacteriol 91:884–889.
Silverstein R, Christoffersen CA, Morrison DC (1989) Modulation of endotoxin lethality in mice by hydrazine sulfate. Infect Immun 57:2072–2078.
Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM, Duncan RC, Tendier MD, Karpf M (1984) The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study. N Engl J Med 311:1137–1143.
Stephens KE, Ishizaka A, Larrick JW, Raffin TA (1988) Tumor necrosis factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury. Am Rev Respir Dis 137:1364–1370.
Stumacher RJ, Kovnat MJ, McCabe WR (1973) Limitations of the usefulness of the limulus assay for endotoxin. N Engl J Med 288:1261–1264.
Suffredini AF, Parker MM, Brenner M, Schlesinger T, Parrillo JE (1987) Endotoxin (E) administration produces abnormal cardiovascular (CV) responses in normal humans. Clin Res 35:386A.
Suffredini AF, Shelhamer JH, Neumann RD, Brenner M, Parrillo JE (1988) Intravenous endotoxin (E) to normal humans caused gas exchange abnormalities and increased alveolar epithelial permeability. Clin Res 36:511A.
Takada H, Galanos C (1987) Enhancement of endotoxin lethality and generation of anaphylactoid reactions by lipopolysaccharides in muramly dipeptide treated mice. Infect Immun 55:409–413.
Tiegs G, Wolter M, Wendel A (1989) Tumor necrosis factor is a terminal mediator in galactosamine endotoxin induced hepatitis in mice. Biochem Pharmacol 38:627–631.
Vas SL, Roy RS, Robson HG (1973) Endotoxin sensitivity of inbred mouse strains. Can J Microbiol 19: 767–769.
Veterans Administration Systemic Sepsis Comparative Study Group (1987) Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of sepsis. N Engl J Med 317:656–665
Wichterman KA, Baue AE, Chaudry IH (1980) Sepsis and septic shock — a review of laboratory models and a proposal. J Surg Res 29:189–201.
Wiles JB, Cerra FB, Siegel JH, Border JR (1980) The systemic septic response: Does the organism matter? Crit Care Med 8:55–60.
Wilmore DW, Goodwin CW, Aulick LM, Powanda MC, Mason AD, Pruitt BA Jr (1980) Effect of injury and infection on visceral metabolism and circulation. Ann Surg 192:491–504.
Wilson DD, DeGaravilla L, Kuhn W, Togo J, Burch RM, Steranka LR (1989) Arg-Hyp3-D-Phe7 bradykinin, a bradykinin antagonist, reduces mortality in a rat model of endotoxic shock. Circ Shock 27:93–101.
Wise WC, Cook JA, Eller T, Halushka PV (1980) Ibuprofen improves survival from endotoxic shock in rat. J Pharmacol Exp Ther 215:160–164.
Wolfe RR, Burke JF (1978) Glucose and lactate metabolism in experimental septic shock. Am J Physiol 235:R219–R227.
Wyler F, Neutze JM, Rudolph AM (1970) The effects of endotoxin on distribution of cardiac output in un-anesthetized rabbits. Am J Physiol 219:246–251.
Zuckerman SH, Bendele AM (1989) Regulation of serum tumor necrosis factor in glucocorticoid sensitive and resistant rodent endotoxin shock models. Infect Immun 57:3009–3013.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bahrami, S., Redl, H., Schlag, G. (1993). Models of Endotoxemia in Rodents. In: Schlag, G., Redl, H. (eds) Pathophysiology of Shock, Sepsis, and Organ Failure. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76736-4_69
Download citation
DOI: https://doi.org/10.1007/978-3-642-76736-4_69
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-76738-8
Online ISBN: 978-3-642-76736-4
eBook Packages: Springer Book Archive